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Abstract
Background: C-reactive protein (CRP) is an acute phase protein that can activate various immune cells and bind to
certain Fcg receptors. The latter may compete with the binding of IgG antibodies to these receptors and could thereby
interfere with the antigen-specific immune response. Polymorphisms in the promoter region of the CRP gene have been
strongly associated with the plasma concentration of CRP. The known lower susceptibility to malaria in the Fulani ethnic
group, as compared to their sympatric neighbours in Africa, has been linked to different genetic backgrounds. The
present study was performed to investigate if polymorphisms in the CRP gene could contribute to the lower
susceptibility to malaria seen in the Fulani ethnic group.
Methods: The CRP -717 T>C, -286 C>T>A, and +1444 C>T polymorphisms were analysed in asymptomatic Fulani and
non-Fulani individuals from Mali and Sudan using Pyrosequencing T and TaqMan r MGB probes.
Results: The rare -286 A allele, previously shown to be associated with increased CRP expression and plasma levels,
was shown to be more frequent in the non-Fulani ethnic groups as compared to the sympatric Fulani ethnic group both
in Mali and Sudan. The common -717 T allele was more prevalent in the non-Fulani ethnic group compared to the
sympatric Fulani ethnic group, but only in Mali. The parasite prevalence was increased for the -286 A allele, but not for
the -717 T allele. No differences regarding genotype frequency or parasite prevalence were seen for +1444 C>T.
Conclusion: This study indicate that CRP may play an important role in the immune responses to malaria, and that the
-286 C/T/A CRP polymorphism may be a contributing factor to the lower susceptibility to malaria seen in the Fulani.
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Background
Malaria, caused by parasites from the Plasmodium genus, is
a prevalent infectious disease worldwide. The Fulani eth-
nic group in Africa has shown a lower susceptibility to
malaria as compared to their sympatric neighbours,
despite being similarly exposed to malaria and having no
obvious differences in socio-cultural circumstances. The
Fulani have lower parasite rates and parasitaemia, higher
anti-malarial immune responses and higher spleen rates
than other sympatric groups [1-3]. It has been previously
shown that this relative resistance to malaria in the Fulani
is pathogen related and not caused by a higher general
reactivity of the immune system [4]. A number of studies
have reported differences between Fulani and non-Fulani
groups in polymorphic immune-related genes [5,6].
Recently, such an inter-ethnic difference in the allele fre-
quencies of a polymorphism in the gene encoding Fca
receptor (R) IIa, resulting in an arginine (R)/histidine (H)-
131 receptor diversity was demonstrated [7,8].
C-reactive protein (CRP) is an acute phase protein, the lev-
els of which increase rapidly in the circulation during
infection and/or inflammation. CRP has the ability to
activate various immune cells and has also shown a possi-
ble capacity to bind to certain FcgR [9]. Fc receptors are
widely expressed on leukocytes and they are important
players in the immune response, the binding of antibod-
ies to these receptors leading to activation and onset of
many important biological events [10]. Interestingly, CRP
shows a sequence homology to the regions in IgG that are
important for FcgR binding [9], indicating that the two
proteins may bind to a common site on these receptors.
The binding of CRP may, therefore, compete with the
binding of IgG antibodies to these receptors, and could
thereby interfere with the antigen-specific immune
response. The FcgRIIa has been shown to have a higher
affinity for CRP if the R131 allele of the receptor is present
[11], the same allele that in some studies has been related
to protection against malaria [12]. Previous studies on fal-
ciparum malaria have related high circulating CRP levels
with parasite density and severity of the malaria infection
[13-15]. Interestingly, in individuals having an asympto-
matic Plasmodium falciparum infection, the plasma levels
of CRP are low [16,17], suggesting that the increased CRP
levels found in P. falciparum symptomatic individuals are
not merely an acute phase response. The role of CRP in P.
falciparum infections is not clear. CRP has been associated
with complement mediated haemolysis of infected eryth-
rocytes and subsequent anaemia [18], but CRP has also
been implicated in the defence against pre-erythrocytic
stages of malaria [19]. Importantly, CRP induces the anti-
inflammatory interleukin (IL)-10 [20], which could affect
the early immune response seen in malaria infections. The
influence of genetic variations on the levels of circulating
CRP is estimated to be 40–60% [21], and single nucle-
otide polymorphisms (SNPs) in different cytokine genes
[22,23] and the CRP gene [24] have been suggested to be
associated with the circulating levels of CRP. The strongest
association with the circulating concentrations of CRP has
been shown for the tri-allelic -286 SNP [25,26], and it has
been suggested that this is a truly functional polymor-
phism in the CRP gene [24]. Previous studies of the -286
C>T>A CRP SNP have revealed that the A allele is more
common in African American than in Caucasian popula-
tions, and that this difference in genotypes is associated
with higher CRP levels in the former population [27]. This
suggests that CRP could have been selected for in the Afri-
can ancestors, as a factor beneficial for survival from infec-
tious diseases.
In order to investigate the possible involvement of CRP in
innate immunity against malaria, and to further define
potential immunological factors contributing to the eth-
nic differences in malaria susceptibility, the -717 T>C
(rs2794521), -286 C>T>A (rs3091244,) +1444 C>T
(rs1130864) CRP genotypes and malariometric indices
were analysed in individuals of sympatric ethnic groups




The study area in Mali is located in the Mopti area about
850 km Northeast of Bamako, the capital of Mali. Four vil-
lages, Mantéourou, Naye, Binédama, and Anakédié were
identified for the study. Malaria transmission is mesoen-
demic in the area, with P. falciparum as the main parasite
species. The entomological inoculation rate is similar in
both ethnic groups [3]. In this area, the dry season extends
from October to May and the rainy season from July to
October.
The study area in Sudan is located in the Daraweesh vil-
lage in the Gedaref State in eastern Sudan, 450 km from
Khartoum and 16 km from the Gedaref town. Malaria
transmission is markedly seasonal and unstable, and
annual peak parasite prevalence ranges from 1 to 40% in
different years, and P. falciparum is responsible for >96%
of the malaria cases [28].
Human samples
In Mali, blood was collected during the rainy season in
September 2005 from 166 Fulani (age range 1–60 years,
median age 15 years, 51% males) and 608 non-Fulani
represented by the Dogon (98%) and Rimaibé (2%) eth-
nic groups (age range 7 month – 61 years, median age 8
years, 44% males). All individuals were asymptomatic at
the time of collection, and parasite prevalence was
detected by microscopy. For PCR, finger prick blood was
collected on filter papers. Spleen enlargement wasMalaria Journal 2009, 8:136 http://www.malariajournal.com/content/8/1/136
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assessed by palpation and graded according to the Hackett
score (0–5). The proportion of individuals that had
enlarged spleens was denoted spleen rate. Informed con-
sent was obtained from all participants or their guardians
and the Ethical committee of the Faculty of Medicine and
Pharmacy, University of Bamako, in Mali and the
National Ethics Committee in Sweden approved the
study.
In Sudan, blood was collected, as part of a longitudinal
study, in May before the rainy seasons between 2004 and
2006, from 225 Fulani (age range 4–75 years, median age
15 years, 36% males) and 100 non-Fulani represented by
the Four (22%), Hausa (28%) and Masaleit (50%) ethnic
groups (age range 2–55 years, median age 17 years, 41%
males). All the individuals were asymptomatic and para-
site negative by microscopy at the time of collection.
Three ml of peripheral blood were collected from all indi-
viduals into vacuum EDTA tubes. The study received ethi-
cal approval from the ethical Committee of University of
Khartoum and national clearance from the Sudanese Min-
istry of Health.
DNA preparation
DNA was extracted from filter papers and venous blood
with Chelex-100 as described previously [5], and then
stored at -20°C. In brief, discs from filter paper or 25 ml
from peripheral blood were incubated overnight in 1 ml
of 0.5% saponin in PBS at 4°C, and were then washed 15–
30 minutes in 1 ml PBS at 4°C. The discs or the pellets,
were then boiled in 200 ml of 5% Chelex-100 in water for
15 minutes, and subsequently DNA was collected in the
supernatants after centrifugation at 8,000 × g for three
minutes.
CRP genotyping
The -286 C>T>A CRP polymorphism (rs3091244) was
analysed using the pyrosequencing method. PCR primers
were designed to amplify the -286 C>T>A polymorphism,
using the forward primer 5'-TGT TTT CCT CAT TTC CCA
GTC T-3' and the reverse primer 5'-biotinylated TGG CTA
TCT ATC CTG CGA AAA T-3' (MWG-Biotech AG, Ebers-
berg, Germany). The PCR amplification was performed in
a 40 ml reaction using 8 ml of genomic DNA template, 20
ml iProof T High-Fidelity Master Mix (BIO-RAD Laborato-
ries, Hercules, CA), and 1.5 ml of each primer (10 pmol/
ml). The PCR was carried out in an Eppendorf Mastercy-
clerr (Eppendorf AG, Hamburg, Germany) using a 30 sec
denaturation at 98°C, followed by 35 cycles with 98°C
for 10 sec, 59°C for 20 sec and 72°C for 15 sec. The final
extension was at 72°C for 5 min. The sequencing primer
was 5'-GTG CAC CCA GAT GGC-3' (MWG-Biotech AG),
and the nucleotide dispensation order was GCA CGT ACA
GT. Sequencing was carried using the PSQ™ 96MA pyrose-
quencing apparatus (Pyrosequencing, Biotage AB, Upp-
sala, Sweden) according to the instructions from the
manufacturer.
The -717 T>C (rs2794521) and +1444 C>T (rs1130864)
CRP polymorphisms were analysed with Taqmanr MGB
Probes from Applied Biosystems according to the manu-
facturers protocol.
Statistical analysis
All statistical analyses were performed in StatView version
5.0.1 unless stated otherwise. Differences in genotype fre-
quencies and allele frequencies between the ethnic groups
were tested for statistical significances using c2 tests. Anal-
yses of the estimated haplotype frequencies and associa-
tions of alleles were performed in Unphased (version
2.403) [29]. Linkage analysis was performed in FStat ver-
sion 2.9.3.2. A P-value of 0.05 or less was considered as
statistically significant.
Results
CRP genotype and allele frequencies
The genotype frequency of the -286 C>T>A polymor-
phism was similar in both countries (Table 1) and was
found to be in Hardy-Weinberg equilibrium. The allele
frequencies were significantly different between the two
ethnic groups in Mali and Sudan (P < 0.0001) (Table 1),
the A allele being at significantly higher frequency in the
non-Fulani groups than in the Fulani groups (Mali: OR =
2.79, P = 1.4 × 10-8 and Sudan: OR = 2.51, P = 8.2 × 10-7,
respectively). While the C allele was found to be at a lower
frequency in the Malian non-Fulani as compared to the
Fulani (OR = 0.36, P = 3 × 10-10), the T allele frequency
was lower in the Sudanese non-Fulani group (OR = 0.28,
P = 4 × 10-7).
Further, the possible influence of the A allele on some
malariometric data collected for the Mali study group
were analysed, and the results revealed that individuals
being parasite positive were more likely to be A-allele car-
riers than parasite negative individuals (p = 0.04) (Table
2), but no differences were seen for genotypes or when
separated based on ethnicity. No differences were seen in
the frequency of splenomegaly (A-allele carriers with
enlarged spleen: 25%, non A-allele carriers with enlarged
spleen: 21%, p = 0.2) or haemoglobin levels (median
(range): A-allele carriers: 11 (5.4–17.5), non A-allele car-
riers: 11 (3.3–17.7), p = 0.8) between A- and non-A allele
carriers.
The genotype frequency of the -717 T>C polymorphism
was similar in both countries (Table 3), and was found to
be in Hardy-Weinberg equilibrium. Both the genotype
and the allele frequencies of the -717 T>C polymorphism
showed a significant difference in Mali, but not in Sudan.
No differences in parasite positive individuals, splenome-Malaria Journal 2009, 8:136 http://www.malariajournal.com/content/8/1/136
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galy or haemoglobin levels were found between the differ-
ent genotypes (data not shown).
The genotype frequency of the +1444 C>T polymorphism
was similar in both countries, and was found to be in
Hardy-Weinberg equilibrium. No differences in either
genotype, allele frequencies (Table 4) or malariometric
indexes (data not shown) in neither Mali nor Sudan were
detected for the +1444 C>T CRP polymorphism
Haplotype associations between CRP -717 T/C, -286 C/T/
A, +1444C/T and FcgRIIa 131 R/H
Both the CRP and FcgRIIa genes are located on chromo-
some 1q21–1q23. Previous investigations of the two allo-
Table 1: Genotype and allele frequencies of the -286 CRP C>T>A polymorphism (rs3091244) in the sympatric ethnic groups in Mali 
and Sudan
Mali Sudan
Fulani (n = 166) Non-Fulani (n = 608) Fulani (n = 225) Non-Fulani (n = 100)
Genotype frequency
AA 6 (4%) 107 (18%) 11 (5%) 17 (17%)
AC 37 (22%) 170 (28%) 42 (19%) 39 (39%)
AT 12 (7%) 113 (19%) 29 (13%) 6 (6%)
CC 62 (29%) 80 (13%) 65 (29%) 25 (25%)
CT 41 (25%) 98 (16%) 56 (25%) 12 (12%)
TT 8 (5%) 40 (7%) 22 (10%) 1 (1%)
P-value < 0.0001 < 0.0001
Allele frequency
A 0.18 0.39 0.21 0.39
C 0.61 0.36 0.51 0.51
T 0.21 0.25 0.28 0.10
P-value < 0.0001 < 0.0001
Frequency of A-allele carriersa
A 55 (33%) 390 (64%) 82 (36%) 62 (62%)
Non-A 111 (67%) 218 (35%) 143 (64%) 38 (38%)
P-value < 0.0001 < 0.0001
a Frequency of individuals with or without at least one A-allele of the -286 CRP polymorphism
Table 2: Frequencies of P. falciparum parasite positive and negative individuals in the -286 CRP genotypes and A-allele carriers from 
Mali.
All Fulani Non-Fulani
Parasitesa: n Positive Nagative n Positive Nagative n Positive Nagative
CRP genotype
AA 113 0.16 0.14 6 0.06 0.03 107 0.18 0.17
AC 207 0.31 0.25 37 0.22 0.22 170 0.32 0.26
AT 125 0.17 0.16 12 0.13 0.06 113 0.18 0.19
CC 142 0.12 0.21 62 0.31 0.39 80 0.09 0.15
CT 139 0.18 0.18 41 0.25 0.25 98 0.16 0.16
TT 48 0.06 0.06 8 0.03 0.05 40 0.07 0.07
P-value 0.2 0.7 0.4
A-allele carrier
A-allele 445 0.64 0.55 55 0.41 0.31 390 0.68 0.62
Non-A 329 0.36 0.45 111 0.59 0.69 218 0.32 0.38
P-value 0.04 0.3 0.18
a Parasite status detected by microscopy.Malaria Journal 2009, 8:136 http://www.malariajournal.com/content/8/1/136
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types of the FcgR131H (rs1801274) polymorphism
showed a difference in allele frequency between the
Fulani and non-Fulani groups in both Mali [7] and Sudan
[30]. These findings, together with the results in this study
regarding the -286 CRP polymorphism, led us to investi-
gate if the haplotype patterns in the FcgRIIa R131H and
CRP -286, -717 and +1444 polymorphisms differ between
the different ethnic groups. The polymorphisms were not
in linkage disequilibrium. A clear pattern was seen with
regards to haplotype patterns, haplotypes containing the
A allele of the -286 CRP polymorphism being exclusively
associated with the non-Fulani group in both Mali and
Sudan (Table 5). This association was regardless of the
FcgRIIa allotypes or the -717 and +1444 CRP polymor-
phisms.
Table 3: Genotype and allele frequencies of the -717 CRP T>C polymorphism (rs2794521) in the sympatric ethnic groups in Mali and 
Sudan
Mali Sudan
Fulani (n = 166) Non-Fulani (n=165) Fulani (n = 211) Non-Fulani (n = 45)
Genotype frequency
CC 8 (5%) 2 (1%) 12 (6%) 3 (7%)
CT 48 (29%) 21 (13%) 59 (28%) 9 (20%)
TT 110 (66%) 142 (86%) 140 (66%) 33 (73%)
P-value < 0.0001 0.5
Allele frequency
C 0.19 0.08 0.20 0.17
T 0.81 0.92 0.80 0.83
P-value < 0.0001 0.5
Frequency of T-allele carriers a
T 158 (95%) 163 (99%) 12 (6%) 199 (94%)
Non-T 8 (5%) 2 (1%) 3 (7%) 42 (93%)
P-value 0.06 0.8
a Frequency of individuals with or without at least one T-allele of the -717 CRP polymorphism
Table 4: Genotype and allele frequencies of the +1444 CRP C>T polymorphism (rs1130864) in the sympatric ethnic groups in Mali and 
Sudan
Mali Sudan
Fulani (n = 166) Non-Fulani (n = 165) Fulani (n = 213) Non-Fulani (n = 46)
Genotype frequency
CC 123 (74%) 130 (79%) 160 (75%) 32 (70%)
CT 41 (25%) 34 (20%) 47 (22%) 14 (30%)
TT 2 (1%) 1 (1%) 6 (3%) 0 (0%)
P-value 0.5 0.3
Allele frequency
C 0.86 0.89 0.86 0.85
T 0.14 0.11 0.14 0.15
P-value 0.3 0.7
Frequency of T-allele carriers a
T 43 (26%) 35 (21%) 53 (25%) 14 (30%)
Non-T 123 (74%) 130 (79%) 160 (75%) 32 (70%)
P-value 0.3 0.4
a Frequency of individuals with or without at least one T-allele of the +1444 CRP polymorphismMalaria Journal 2009, 8:136 http://www.malariajournal.com/content/8/1/136
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Discussion
The present study demonstrates striking differences
regarding CRP single nucleotide polymorphisms between
sympatric ethnic groups, which may contribute to the dif-
ferences in their susceptibility to malaria. In particular, the
CRP SNP -286 C/T/A showed a marked difference in gen-
otype frequencies between Fulani and non-Fulani individ-
uals in two independent cohorts from Mali and Sudan.
Lower frequencies of the A-allele of this SNP, previously
associated with higher circulating CRP concentrations,
were demonstrated in the two independent Fulani groups
as compared to other sympatric ethnic groups. Moreover,
a higher parasite prevalence was detected in individuals
with the A allele, supporting the cause-relationship. The
other two analysed polymorphisms did not show any
consistent differences between Mali and Sudan, and in the
haplotype analysis it was clearly the -286 A-allele that
showed a consistent association with one ethnic group in
both countries. The results suggest that the -286 CRP pol-
ymorphism may be a contributing factor in the lower sus-
ceptibility to malaria seen in the Fulani group.
However, the hypothesis that the -286 A-allele is associ-
ated with protection against infectious diseases due to a
selection in African populations was refuted. The reason
for this is not clear, but the A-allele might be associated
with a lower risk of other diseases, as discussed below.
So far, inconclusive results, suggesting both a beneficial
and harmful role of CRP in malaria [18,19], have made it
difficult to conclude about its role in the disease. How-
ever, a recent study showed that binding of CRP to
infected red blood cells (RBCs) increased the removal of
damaged RBCs from the circulation [31], which could
lead to a more pronounced anaemia. Further, the control
of  P. falciparum parasitaemia is dependent on a pro-
inflammatory response, and an uncontrolled inflamma-
tion is suggested to cause severe symptoms [32]. Higher
levels of circulating CRP could influence the IL-10 levels
and thereby affect the delicate balance between pro- and
anti-inflammatory responses, leading to a reduced control
of parasitaemia. Support for this notion comes from pre-
vious studies showing high circulating CRP levels in indi-
viduals with high parasitaemia [13,14], indicating an
effect of CRP on parasite clearance. IL-10 is also involved
in the generation of peripheral regulatory T cells (Treg)
[33]. The up-regulation of Tregs in a malaria infection has
been shown to increase the parasite growth [34], and a
recent study demonstrated that the Fulani present a func-
tionally impaired Treg repertoire as compared to their
sympatric neighbours [35]. Moreover, CRP may show
direct effects on dendritic cell differentiation, maturation
and function [36], and neutrophil chemotaxis and signal-
ling [37]. Since dendritic cells are important in initiating
and regulating immune responses, and neutrophils have
shown a protective effect against malaria in vitro [38,39],
such influences may seriously hamper an effective
immune response.
Low levels of CRP have been shown for a number of
autoimmune diseases [40], and with the predicted low
levels of circulating CRP in the Fulani groups, it could be
assumed that the Fulani may be more susceptible to
autoimmune diseases, and this is true for some disorders,





















Reference haplotype HA AC AC HAC ACC HAC HACC
N HA RA AT AC HAT RAT ATC HAC HATC RATC
Non-Fulani 159 0.20 0.19 0.39 0.39 0.20 0.19 0.39 0.21 0.20 0.19
Fulani 164 0.09 0.09 0.18 0.18 0.09 0.09 0.18 0.7 0.09 0.09
OR 2.57 2.26 2.79 2.79 2.58 2.29 2.79 3.6 2.6 2.28
P-value 0.0001 0.0006 1 × 10-8 1 × 10-8 0.0001 0.0005 1 × 10-8 1 × 10-8 0.0001 0.0004
Sudan
N HA RA AT AC HAT RAT ATC HAT RAC HATC RATC
Non-Fulani 100 0.21 0.18 0.41 0.41 0.22 0.18 0.41 0.25 0.17 0.24 0.17
Fulani 225 0.13 0.08 0.21 0.21 0.13 0.08 0.21 0.12 0.08 0.13 0.09
OR 1.88 2.52 2.65 2.66 2.05 2.6 2.65 2.33 2.24 2.19 2.42
P-value 0.007 0.0003 0.0001 0.0001 0.03 0.006 0.0001 0.005 0.03 0.01 0.02
* The data for the FcgRIIa 131 R/H from Mali was obtained from Israelsson et al [7], and from Sudan from Nasr et al [30]Malaria Journal 2009, 8:136 http://www.malariajournal.com/content/8/1/136
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e.g. diabetes [41]. The results of the present study may
suggest, that a high level of circulating CRP can be detri-
mental for malaria protection, although by a yet unknown
mechanism. The supporting promising finding of a higher
frequency of parasite positive individuals among -286 A-
allele carriers than among the non-A-allele carriers further
strengthens this hypothesis. One limitation of the present
study is that no reliable data on plasma levels of CRP
could be presented due to lack of plasma in Mali and to
lack of standardisation of blood sampling in Sudan. In
future studies there is a need to study both unstimulated
and plasma levels stimulated by malaria in relation to
CRP genotypes in Africa.
The FcgRIIa 131 H/R polymorphism has been associated
with malaria susceptibility in several studies [12,42,43].
CRP binds with a higher affinity to the receptor expressed
by the R allele [11], which might have a competitive effect
on the binding of the previously shown malaria protective
immunoglobulins (Ig) G1 and IgG3 [44], thereby interfer-
ing with the protection against malaria. Since the CRP
gene and the FcgRIIa gene are located in the same region
on chromosome 1, the possibility of a susceptibility locus
on this chromosome was investigated. Although the link-
age analysis did not show any linkage between these two
polymorphisms, associations were found between haplo-
types containing the -286 A-allele, regardless of the
FcgRIIa allotype or the -717 or +1444 CRP polymor-
phisms, and the non-Fulani groups. This finding suggests
that the -286 CRP polymorphism could have a stronger
impact on malaria susceptibility than the other investi-
gated variants. The finding that there are more parasite
positive individuals among the A-allele carriers than
among the non-A allele carriers, further strengthens this
suggestion. The sample size in this study was probably too
small for making any firm conclusions, but the results
strongly indicate a need for further studies on the impact
of CRP in relation to susceptibility to malaria.
Conclusion
In conclusion, this study has demonstrated a marked dif-
ference in CRP genotype frequencies in two independent
samples of Africans with low susceptibility to malaria as
compared to sympatric ethnic groups. The -286 CRP pol-
ymorphism that was analysed has been shown to be func-
tional in vitro, and associated with in vivo CRP levels in the
circulation. This study further shows that the high produc-
ing -286 A-allele may be associated with parasitaemia,
and it can, therefore, be speculated that CRP play a role in
the early immune response to malaria infection. This may
possibly occur by inhibiting dendritic cells and/or neu-
trophils, by competition with the binding of malaria spe-
cific IgG antibodies to Fcg receptors, by enhance the
clearance of infected RBCs, leading to more severe anae-
mia, or a deviation towards an anti-inflammatory
cytokine response induced by CRP. Further research on
the effect of CRP on malaria susceptibility is warranted,
since recent studies on new therapeutic agents, that lower
the circulating CRP levels [45], might open up new
adjunct treatment options against malaria.
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